Orthofix International reported $157.01M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 106.93M 14.23M Jun/2026
AtriCure USD 81.92M 8.72M Jun/2026
Dexcom USD 2.36B 133.9M Jun/2026
EDAP TMS EUR 37.51M 6.1M Mar/2026
Globus Medical USD 479.35M 3.12M Jun/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 744.2M 56.7M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
J&J USD 54.9B 2.82B Jun/2026
Medtronic USD 11.66B 2.16B Mar/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 157.01M 4.02M Jun/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Smith & Nephew USD 2.05B 510M Jun/2026
STAAR Surgical USD 73.39M 12.4M Jun/2026
Stryker USD 6.68B 369M Jun/2026
Tandem Diabetes Care USD 253M 5.05M Jun/2026
Teleflex USD 720.38M 7.67M Jun/2026
Veracyte USD 62.74M 6.62M Jun/2026
Zimmer Biomet Holdings USD 3.01B 149.2M Jun/2026